date,title,source
Oct-23-18,"Report: Exploring Fundamental Drivers Behind Alder BioPharmaceuticals, DURECT, Mettler-Toledo International, Internap, Career Education, and Approach Resources  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-25-18,DURECT Announces Abstracts on DUR-928 to be Presented at Upcoming Scientific Meetings,PR Newswire
Nov-01-18,DURECT Corporation Invites You to Join its Third Quarter 2018 Earnings Conference Call,PR Newswire
Nov-07-18,Durect: 3Q Earnings Snapshot,Associated Press
Nov-07-18,DURECT Corporation Announces Third Quarter 2018 Financial Results and Provides Corporate Update,PR Newswire
Nov-09-18,Edited Transcript of DRRX earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-13-18,Could DURECT Corporations (NASDAQ:DRRX) Investor Composition Influence The Stock Price?,Simply Wall St.
Nov-16-18,DRRX: Protocol Amendment Speeds DUR-928 Ph2 AH Trial. PERSERIS FDA Approval Adds New Revenue Stream,Zacks Small Cap Research
Nov-19-18,DURECT Announces Amendment to Accelerate Ongoing Phase 2a Trial of DUR-928 in Alcoholic Hepatitis (AH) by Allowing Dosing of Severe AH Patients in Parallel to Moderate AH Patients,PR Newswire
Nov-30-18,"Analysis: Positioning to Benefit within News Corporation, DURECT, Ecolab, MiX Telematics, Ship Finance International, and BCE  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Dec-13-18,Edited Transcript of DRRX earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Dec-17-18,DURECT Corporation Announces Retirement of Dr. Felix Theeuwes as Chairman of the Board and Distinguished Scientist,PR Newswire
Dec-19-18,Commercial Launch Plans Announced for PERSERIS (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults,PR Newswire
Jan-03-19,DURECT Corporation Announces Investor Call to Provide Corporate Update,PR Newswire
Jan-04-19,Heres What We Think About DURECT Corporations (NASDAQ:DRRX) CEO Pay,Simply Wall St.
Jan-07-19,DURECT Corporation Provides Corporate Update,PR Newswire
Jan-09-19,Edited Transcript of DRRX earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Jan-10-19,Edited Transcript of DRRX earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Jan-11-19,DRRX: Pipeline Update: Focus Is On Accelerating DUR-928 in NASH and Other High-Potential Indications,Zacks Small Cap Research
Jan-24-19,Streetwise Reports Examines the Commercial Launch Planned for Schizophrenia Drug,GlobeNewswire
Feb-21-19,DURECT Corporation to Participate in the Berenberg NASH Day,PR Newswire
Feb-22-19,"Factors of Influence in 2019, Key Indicators and Opportunity within ARRIS International plc, Edwards Lifesciences, DENTSPLY SIRONA, Vail Resorts, Akers Biosciences, and DURECT  New Research Emphasizes Economic Growth",GlobeNewswire
Feb-26-19,DURECT Corporation (NASDAQ:DRRX): Time For A Financial Health Check,Simply Wall St.
Mar-04-19,DURECT Corporation Invites You to Join its Fourth Quarter 2018 Earnings Conference Call,PR Newswire
Mar-07-19,DURECT Corporation Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs,PR Newswire
Mar-08-19,Edited Transcript of DRRX earnings conference call or presentation 7-Mar-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-13-19,Edited Transcript of DRRX earnings conference call or presentation 7-Mar-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-13-19,"DRRX: DUR-928 Programs Accelerating. Anticipate NASH, Psoriasis Data Later This Year",Zacks Small Cap Research
Mar-21-19,DURECT Announces Patient Dosing in Phase 2a Proof-of-Concept Clinical Trial of Topical DUR-928 in Patients with Mild to Moderate Plaque Psoriasis,PR Newswire
Mar-27-19,DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alcoholic Steatohepatitis (NASH),PR Newswire
Apr-01-19,DURECT to Present at the H.C. Wainwright Global Life Sciences Conference and Host an Upcoming KOL call on NASH,PR Newswire
Apr-22-19,DURECT Corporation (NASDAQ:DRRX): What's The Analyst Consensus Outlook?,Simply Wall St.
